お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はオンコロジー創薬サービス市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはオンコロジー創薬サービスの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のオンコロジー創薬サービス市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはオンコロジー創薬サービスのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にオンコロジー創薬サービス市場を分類しています。本研究に含まれる主な企業は：Charles River、Evotec、GE Healthcare Life Sciences、GenScript、Horizon Discovery、TCG Lifesciences、Zumutor、ChemPartner、Aquila BioMedical、Onconova、Vichem Chemie、GVK Biosciences、NuChem Therapeutics、Syncom、Envigo、DiverChim、Aurora、HD Biosciences、WuXi AppTec

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Identification Service
    Authentication Service
    Hit-to-lead and Lead Optimization Services
    Others

用途別の市場セグメント：
    Research Institutes
    Pharmaceutical Companies
    Biotechnology Companies
    Others

本レポートの詳細内容
世界のオンコロジー創薬サービス市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、オンコロジー創薬サービスタイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のオンコロジー創薬サービス収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のオンコロジー創薬サービス市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、オンコロジー創薬サービス市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

オンコロジー創薬サービスのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：オンコロジー創薬サービスのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：オンコロジー創薬サービスの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章オンコロジー創薬サービス企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：オンコロジー創薬サービスの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：オンコロジー創薬サービスの主要企業の概要を提供し、製品の説明と仕様、オンコロジー創薬サービスの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

The Oncology Drug Discovery Service is dedicated to oncology research, providing high-quality, timely and cost-effective oncology drug discovery and accelerating the development of the immunooncology product portfolio to develop new drugs that benefit human health.

Market Analysis and Insights: Global Oncology Drug Discovery Services Market
The global Oncology Drug Discovery Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Oncology Drug Discovery Services market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Oncology Drug Discovery Services, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Oncology Drug Discovery Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oncology Drug Discovery Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Oncology Drug Discovery Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Oncology Drug Discovery Services revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Charles River, Evotec, GE Healthcare Life Sciences, GenScript, Horizon Discovery, TCG Lifesciences, Zumutor, ChemPartner and Aquila BioMedical, etc.

Market Segmentation
By Company
    Charles River
    Evotec
    GE Healthcare Life Sciences
    GenScript
    Horizon Discovery
    TCG Lifesciences
    Zumutor
    ChemPartner
    Aquila BioMedical
    Onconova
    Vichem Chemie
    GVK Biosciences
    NuChem Therapeutics
    Syncom
    Envigo
    DiverChim
    Aurora
    HD Biosciences
    WuXi AppTec

Segment by Type
    Identification Service
    Authentication Service
    Hit-to-lead and Lead Optimization Services
    Others

Segment by Application
    Research Institutes
    Pharmaceutical Companies
    Biotechnology Companies
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Oncology Drug Discovery Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology Drug Discovery Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Drug Discovery Services revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Oncology Drug Discovery Services Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Identification Service
    Table 3. Key Players of Authentication Service
    Table 4. Key Players of Hit-to-lead and Lead Optimization Services
    Table 5. Key Players of Others
    Table 6. Global Oncology Drug Discovery Services Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Oncology Drug Discovery Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Oncology Drug Discovery Services Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Oncology Drug Discovery Services Market Share by Region (2019-2024)
    Table 10. Global Oncology Drug Discovery Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Oncology Drug Discovery Services Market Share by Region (2025-2030)
    Table 12. Oncology Drug Discovery Services Market Trends
    Table 13. Oncology Drug Discovery Services Market Drivers
    Table 14. Oncology Drug Discovery Services Market Challenges
    Table 15. Oncology Drug Discovery Services Market Restraints
    Table 16. Global Oncology Drug Discovery Services Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Oncology Drug Discovery Services Revenue Share by Players (2019-2024)
    Table 18. Global Top Oncology Drug Discovery Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drug Discovery Services as of 2023)
    Table 19. Global Oncology Drug Discovery Services Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Oncology Drug Discovery Services Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Oncology Drug Discovery Services, Headquarters and Area Served
    Table 22. Global Key Players of Oncology Drug Discovery Services, Product and Application
    Table 23. Global Key Players of Oncology Drug Discovery Services, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Oncology Drug Discovery Services Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Oncology Drug Discovery Services Revenue Market Share by Type (2019-2024)
    Table 27. Global Oncology Drug Discovery Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Oncology Drug Discovery Services Revenue Market Share by Type (2025-2030)
    Table 29. Global Oncology Drug Discovery Services Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Oncology Drug Discovery Services Revenue Share by Application (2019-2024)
    Table 31. Global Oncology Drug Discovery Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Oncology Drug Discovery Services Revenue Share by Application (2025-2030)
    Table 33. North America Oncology Drug Discovery Services Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Oncology Drug Discovery Services Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Oncology Drug Discovery Services Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Oncology Drug Discovery Services Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Oncology Drug Discovery Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Oncology Drug Discovery Services Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Oncology Drug Discovery Services Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Oncology Drug Discovery Services Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Oncology Drug Discovery Services Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Oncology Drug Discovery Services Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Oncology Drug Discovery Services Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Oncology Drug Discovery Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Oncology Drug Discovery Services Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Oncology Drug Discovery Services Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Oncology Drug Discovery Services Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Oncology Drug Discovery Services Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Oncology Drug Discovery Services Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Oncology Drug Discovery Services Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Oncology Drug Discovery Services Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Oncology Drug Discovery Services Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Oncology Drug Discovery Services Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Oncology Drug Discovery Services Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Oncology Drug Discovery Services Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Oncology Drug Discovery Services Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Oncology Drug Discovery Services Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Oncology Drug Discovery Services Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Oncology Drug Discovery Services Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Oncology Drug Discovery Services Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Oncology Drug Discovery Services Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Oncology Drug Discovery Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Oncology Drug Discovery Services Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Oncology Drug Discovery Services Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Charles River Company Details
    Table 66. Charles River Business Overview
    Table 67. Charles River Oncology Drug Discovery Services Product
    Table 68. Charles River Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 69. Charles River Recent Developments
    Table 70. Evotec Company Details
    Table 71. Evotec Business Overview
    Table 72. Evotec Oncology Drug Discovery Services Product
    Table 73. Evotec Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 74. Evotec Recent Developments
    Table 75. GE Healthcare Life Sciences Company Details
    Table 76. GE Healthcare Life Sciences Business Overview
    Table 77. GE Healthcare Life Sciences Oncology Drug Discovery Services Product
    Table 78. GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 79. GE Healthcare Life Sciences Recent Developments
    Table 80. GenScript Company Details
    Table 81. GenScript Business Overview
    Table 82. GenScript Oncology Drug Discovery Services Product
    Table 83. GenScript Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 84. GenScript Recent Developments
    Table 85. Horizon Discovery Company Details
    Table 86. Horizon Discovery Business Overview
    Table 87. Horizon Discovery Oncology Drug Discovery Services Product
    Table 88. Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 89. Horizon Discovery Recent Developments
    Table 90. TCG Lifesciences Company Details
    Table 91. TCG Lifesciences Business Overview
    Table 92. TCG Lifesciences Oncology Drug Discovery Services Product
    Table 93. TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 94. TCG Lifesciences Recent Developments
    Table 95. Zumutor Company Details
    Table 96. Zumutor Business Overview
    Table 97. Zumutor Oncology Drug Discovery Services Product
    Table 98. Zumutor Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 99. Zumutor Recent Developments
    Table 100. ChemPartner Company Details
    Table 101. ChemPartner Business Overview
    Table 102. ChemPartner Oncology Drug Discovery Services Product
    Table 103. ChemPartner Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 104. ChemPartner Recent Developments
    Table 105. Aquila BioMedical Company Details
    Table 106. Aquila BioMedical Business Overview
    Table 107. Aquila BioMedical Oncology Drug Discovery Services Product
    Table 108. Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 109. Aquila BioMedical Recent Developments
    Table 110. Onconova Company Details
    Table 111. Onconova Business Overview
    Table 112. Onconova Oncology Drug Discovery Services Product
    Table 113. Onconova Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 114. Onconova Recent Developments
    Table 115. Vichem Chemie Company Details
    Table 116. Vichem Chemie Business Overview
    Table 117. Vichem Chemie Oncology Drug Discovery Services Product
    Table 118. Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 119. Vichem Chemie Recent Developments
    Table 120. GVK Biosciences Company Details
    Table 121. GVK Biosciences Business Overview
    Table 122. GVK Biosciences Oncology Drug Discovery Services Product
    Table 123. GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 124. GVK Biosciences Recent Developments
    Table 125. NuChem Therapeutics Company Details
    Table 126. NuChem Therapeutics Business Overview
    Table 127. NuChem Therapeutics Oncology Drug Discovery Services Product
    Table 128. NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 129. NuChem Therapeutics Recent Developments
    Table 130. Syncom Company Details
    Table 131. Syncom Business Overview
    Table 132. Syncom Oncology Drug Discovery Services Product
    Table 133. Syncom Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 134. Syncom Recent Developments
    Table 135. Envigo Company Details
    Table 136. Envigo Business Overview
    Table 137. Envigo Oncology Drug Discovery Services Product
    Table 138. Envigo Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 139. Envigo Recent Developments
    Table 140. DiverChim Company Details
    Table 141. DiverChim Business Overview
    Table 142. DiverChim Oncology Drug Discovery Services Product
    Table 143. DiverChim Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 144. DiverChim Recent Developments
    Table 145. Aurora Company Details
    Table 146. Aurora Business Overview
    Table 147. Aurora Oncology Drug Discovery Services Product
    Table 148. Aurora Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 149. Aurora Recent Developments
    Table 150. HD Biosciences Company Details
    Table 151. HD Biosciences Business Overview
    Table 152. HD Biosciences Oncology Drug Discovery Services Product
    Table 153. HD Biosciences Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 154. HD Biosciences Recent Developments
    Table 155. WuXi AppTec Company Details
    Table 156. WuXi AppTec Business Overview
    Table 157. WuXi AppTec Oncology Drug Discovery Services Product
    Table 158. WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2019-2024) & (US$ Million)
    Table 159. WuXi AppTec Recent Developments
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Drug Discovery Services Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Oncology Drug Discovery Services Market Share by Type: 2023 VS 2030
    Figure 3. Identification Service Features
    Figure 4. Authentication Service Features
    Figure 5. Hit-to-lead and Lead Optimization Services Features
    Figure 6. Others Features
    Figure 7. Global Oncology Drug Discovery Services Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Oncology Drug Discovery Services Market Share by Application: 2023 VS 2030
    Figure 9. Research Institutes Case Studies
    Figure 10. Pharmaceutical Companies Case Studies
    Figure 11. Biotechnology Companies Case Studies
    Figure 12. Others Case Studies
    Figure 13. Oncology Drug Discovery Services Report Years Considered
    Figure 14. Global Oncology Drug Discovery Services Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Oncology Drug Discovery Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Oncology Drug Discovery Services Market Share by Region: 2023 VS 2030
    Figure 17. Global Oncology Drug Discovery Services Market Share by Players in 2023
    Figure 18. Global Top Oncology Drug Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drug Discovery Services as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Oncology Drug Discovery Services Revenue in 2023
    Figure 20. North America Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Oncology Drug Discovery Services Market Share by Type (2019-2030)
    Figure 22. North America Oncology Drug Discovery Services Market Share by Application (2019-2030)
    Figure 23. North America Oncology Drug Discovery Services Market Share by Country (2019-2030)
    Figure 24. United States Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Oncology Drug Discovery Services Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Oncology Drug Discovery Services Market Share by Type (2019-2030)
    Figure 28. Europe Oncology Drug Discovery Services Market Share by Application (2019-2030)
    Figure 29. Europe Oncology Drug Discovery Services Market Share by Country (2019-2030)
    Figure 30. Germany Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Oncology Drug Discovery Services Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Oncology Drug Discovery Services Market Share by Type (2019-2030)
    Figure 38. China Oncology Drug Discovery Services Market Share by Application (2019-2030)
    Figure 39. Asia Oncology Drug Discovery Services Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Oncology Drug Discovery Services Market Share by Type (2019-2030)
    Figure 41. Asia Oncology Drug Discovery Services Market Share by Application (2019-2030)
    Figure 42. Asia Oncology Drug Discovery Services Market Share by Region (2019-2030)
    Figure 43. Japan Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Oncology Drug Discovery Services Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Oncology Drug Discovery Services Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Oncology Drug Discovery Services Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Oncology Drug Discovery Services Market Share by Country (2019-2030)
    Figure 53. Brazil Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Oncology Drug Discovery Services Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Charles River Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 60. Evotec Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 61. GE Healthcare Life Sciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 62. GenScript Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 63. Horizon Discovery Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 64. TCG Lifesciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 65. Zumutor Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 66. ChemPartner Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 67. Aquila BioMedical Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 68. Onconova Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 69. Vichem Chemie Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 70. GVK Biosciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 71. NuChem Therapeutics Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 72. Syncom Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 73. Envigo Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 74. DiverChim Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 75. Aurora Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 76. HD Biosciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 77. WuXi AppTec Revenue Growth Rate in Oncology Drug Discovery Services Business (2019-2024)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed